News from NORD

Neuroendocrine Tumor Research Foundation Posts RFPs for $1.2 Million in Grants

“Accelerator Grants” to advance research to cure neuroendocrine cancers have just been announced by the Neuroendocrine Tumor Research Foundation. With these grants, NETRF is launching the most ambitious privately funded global research effort ever undertaken to control and cure neuroendocrine cancers.

NETRF is seeking proposals for significant NET research projects with each grant award of up to $1.2 million over four years. “NETRF seeks to fund the most dedicated teams and robust proposals to transform the landscape of NET research,” said Lauren Erb, Director of Research.

The Accelerator Grants program was established by automobile publishing giant Robert Petersen, who passed away from neuroendocrine cancer in 2007. Competitive proposals are being sought in this international program and all proposals will be evaluated in a rigorous review process by the NETRF Board of Scientific Advisors.


 

Recommended Reading

Bone disease in patients with kidney disease: A tricky interplay
MDedge Family Medicine
NORD Rare Diseases and Orphan Products Summit to Feature Speakers from FDA, NIH, and ACMG
MDedge Family Medicine
NORD Issues Statement as US Senate Postpones Vote on Cures Legislation
MDedge Family Medicine
3rd World Congress on Cutaneous Lymphomas to Take Place October 26-28
MDedge Family Medicine
Primary biliary cholangitis: Obeticholic acid reduces biomarkers
MDedge Family Medicine
Funding Announced for Alport Syndrome Research
MDedge Family Medicine
Myth of the Month: Vaccinations in patients with Guillain-Barré syndrome
MDedge Family Medicine
SHARE initiative releases consensus-based JDM management recommendations
MDedge Family Medicine
CANDLE syndrome case highlights key features of this type 1 interferonopathy
MDedge Family Medicine
Research Training Fellowship in Ataxia is Available
MDedge Family Medicine